一心堂(002727.SZ)披露收購宜賓老百姓藥房門店資產及其存貨的進展
格隆匯 2 月 5日丨一心堂(002727.SZ)公佈,公司2020年第14次總裁辦公會討論決定同意公司全資子公司四川一心堂醫藥連鎖有限公司收購宜賓市老百姓大藥房有限責任公司(“宜賓老百姓藥房”,該宜賓老百姓藥房與上市公司老百姓大藥房連鎖股份有限公司無關聯關係)所持有7家門店資產及其存貨,併發布《關於全資子公司四川一心堂醫藥連鎖有限公司收購宜賓市老百姓大藥房有限責任公司門店資產及其存貨的公吿》(公吿編號:2020-205號)。
截至公吿日,已按協議約定完成全部7家門店鋪面租賃合同改簽,門店固定資產及存貨盤點交接,並取得新的營業執照、藥品經營許可證,門店已開始營業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.